Olicom A/S Company, Decuma AB has today announced that Sony releases CLIE Handhelds PEG-NX73V and PEG-NX80V with Decuma Japanese Handwriting Recognition
May 27, 2003 04:03 ET
|
Olicom A/S
COPENHAGEN, Denmark, May 27, 2003 (PRIMEZONE) -- Decuma, a leading developer of software solutions for handwriting recognition, announces a licensing agreement with Sony Corporation. Sony will start...
BBH acquires yet another brewery in Kazakhstan
May 27, 2003 03:21 ET
|
Orkla ASA
The Ak-Nar brewery is newly built and has a capacity of 60 million litres beer, and the capacity can be expanded at low costs. In November last year, BBH acquired 76 per cent of the Irbis brewery also...
BBH kjøper nok et bryggeri i Kazakhstan
May 27, 2003 03:15 ET
|
Orkla ASA
Baltic Beverages Holding (BBH) har underskrevet en avtale om å kjøpe hele aksjekapitalen i bryggeriet Ak-Nar i Alma-Ata, Kazakhstan for ca. NOKm 200 (USDm 30). Selgerne er European Bank for...
BOWE SYSTEC-Group Starts 2003 With New Strength
May 27, 2003 03:11 ET
|
BOWE SYSTEC AG
Augsburg, Germany, May 27, 2003 (PRIMEZONE) -- BOWE SYSTEC AG (Other
OTC:BOEWF):
-- Consolidated sales +75% and order intake +86%
-- 50% participation at BOWE Bell + Howell, USA included for...
Orion Pharma introduces negotiations with Finnish personnel representatives aiming at major operational rearrangements
May 27, 2003 03:07 ET
|
Orion Oyj
Negotiations with the Finnish personnel representatives are being introduced in the Orion Pharma business division of Orion Corporation concerning rearrangements necessitated by the need to...
Orion Pharmassa annetaan Suomen toiminnot laajasti kattava yt-neuvotteluesitys uudelleenjärjestelyistä
May 27, 2003 03:01 ET
|
Orion Oyj
Orion-yhtymä Oyj Orion Pharma esittää tänään Suomen toimintojen luottamushenkilöille yt-neuvottelujen aloittamista uudelleenjärjestelyistä, jotka liittyvät yksikön taloudellisen ja toiminnallisen...
Novartis: New clinical research data on Glivec®
May 27, 2003 01:30 ET
|
Novartis Pharma AG
New clinical research data on Glivec® in variety of cancers to be presented at American Society of Clinical Oncology meeting
Latest clinical research findings examine the potential of Glivec...
Aktionärsbrief
May 27, 2003 01:07 ET
|
Private Equity Holding AG
Sehr geehrte Aktionärinnen und Aktionäre
Die grösste Herausforderung des Geschäftsjahrs 2002/ 2003 bestand darin, ausreichende Finanzierungsmittel sicherzustellen. Eine Kombination aus...
Shareholder Letter
May 27, 2003 01:02 ET
|
Private Equity Holding AG
Dear Shareholders
Securing adequate financial resources represented the major challenge throughout 2002/2003. By the end of the financial year, the combination of concurrent adverse market...
Private Equity Holding AG: Annual Results 2002/2003
May 27, 2003 01:00 ET
|
Private Equity Holding AG
Securing adequate financial resources represented the major challenge throughout 2002/2003. By the end of the financial year, the combination of concurrent adverse market conditions including...
- July 30, 2024 08:15 ET Acronis H1 2024 Cyberthreats Report Highlights a 293% Surge in Email Attacks
- July 30, 2024 08:03 ET Lofty Introduces Property Management System, LoftyWorks